Carcinoma, Renal Cell
Showing 1 - 25 of 185
Tumors, Kidney Tumors, Urologic Tumors Trial in Nanjing (Toripalimab, Axitinib, Lenvatinib)
Recruiting
- Neoplasms
- +12 more
- Toripalimab
- +3 more
-
Nanjing, Jiangsu, ChinaJinling Hospital, Affiliated Hospital of Medical School, Nanjing
Oct 28, 2023
Clinical Factors on Prognosis of Papillary Renal Cell Carcinoma
Completed
- Carcinoma, Renal Cell
- We do not have any interventions. This study is based on obseravation.
- (no location specified)
Oct 27, 2023
Carcinoma, Renal Cell Trial in China (Pembrolizumab, Belzutifan, Pembrolizumab/Quavonlimab)
Recruiting
- Carcinoma, Renal Cell
- Pembrolizumab
- +3 more
-
Beijing, Beijing, China
- +16 more
Jun 2, 2023
Carcinoma, Renal Cell, NSCLC Trial in Belgium, France (Live Bacterial Product - Akkermansia muciniphila)
Recruiting
- Carcinoma, Renal Cell
- Carcinoma, Non-Small-Cell Lung
- Live Bacterial Product - Akkermansia muciniphila
-
Mons, Belgium
- +3 more
May 9, 2023
Sutureless Zero Ischemia Laparoscopic Tumor Enucleation for T1
Recruiting
- Carcinoma, Renal Cell
- Kidney Neoplasms
-
Yiwu, Zhejiang, ChinaThe Fourth Affiliated Hospital Zhejiang University School of Med
Mar 27, 2023
go Back Into Records and Observe How People With Metastatic
Not yet recruiting
- Carcinoma, Renal Cell
- Clear-cell Metastatic Renal Cell Carcinoma
-
Istanbul, TurkeyPfizer
Feb 15, 2023
Three-dimensional Virtual Imaging to Improve Accuracy of
Completed
- Kidney Neoplasms
- Carcinoma, Renal Cell
- 3D-PADUA nephrometric score
- 2D-PADUA nephrometric score
-
Orbassano, TO, ItalySan Luigi Gonzaga Hospital
Feb 6, 2023
Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, MK-4830, Belzutifan)
Recruiting
- Carcinoma, Renal Cell
- Pembrolizumab
- +5 more
-
New Haven, Connecticut
- +38 more
Jan 25, 2023
Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, Favezelimab/Pembrolizumab, Belzutifan)
Recruiting
- Carcinoma, Renal Cell
- Pembrolizumab
- +5 more
-
New Haven, Connecticut
- +37 more
Jan 25, 2023
Carcinoma, Renal Cell Trial in Worldwide (Atezolizumab, Cabozantinib)
Active, not recruiting
- Carcinoma, Renal Cell
-
Tucson, Arizona
- +147 more
Jan 24, 2023
Carcinoma, Carcinoma, Renal Cell, Kidney Tumors Trial in Worldwide (Savolitinib, Sunitinib)
Active, not recruiting
- Carcinoma
- +7 more
-
La Jolla, California
- +58 more
Jan 13, 2023
Carcinoma, Renal Cell Trial in Madison (Stereotactic Body Radiation Therapy (SBRT), Microwave Ablation (MWA))
Active, not recruiting
- Carcinoma, Renal Cell
- Stereotactic Body Radiation Therapy (SBRT)
- Microwave Ablation (MWA)
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Jan 9, 2023
Carcinoma, Renal Cell Trial in Pittsburgh (Autologous alpha-DC1/TBVA vaccine, Cabozantinib)
Not yet recruiting
- Carcinoma, Renal Cell
- Autologous alpha-DC1/TBVA vaccine
- Cabozantinib
-
Pittsburgh, PennsylvaniaUPMC Department of Urology
Jan 5, 2023
NSCLC, Cutaneous Melanoma, Carcinoma, Renal Cell Trial (KFA115, tislelizumab)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- +10 more
-
Singapore, SingaporeNovartis Investigative Site
Nov 16, 2022
Immune Checkpoint Inhibitors in Genitourinary Malignancies
Suspended
- Carcinoma, Renal Cell
- Carcinoma, Urothelial
- Immune cell and CTC detection procedures
-
Durham, North CarolinaDuke University Medical Center
Nov 11, 2022
Based on Evidence-based Pathological Diagnose Criteria for RCC
Not yet recruiting
- Carcinoma, Renal Cell
- +3 more
- Vascular wall invaded
- (no location specified)
Oct 18, 2022
Efficacy and Safety of Avelumab + Axitinib Combination in aRCC
Recruiting
- Carcinoma, Renal Cell
-
Bonheiden, Belgium
- +77 more
Sep 16, 2022
Among Advanced Renal Cell Carcinoma Receiving Systemic
Not yet recruiting
- Carcinoma, Renal Cell
- (no location specified)
Sep 6, 2022
Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, Belzutifan, Pembrolizumab/Quavonlimab)
Recruiting
- Carcinoma, Renal Cell
- Pembrolizumab
- +3 more
-
Birmingham, Alabama
- +229 more
Aug 11, 2022
NSCLC, Carcinoma, Renal Cell, Esophageal Squamous Cell Carcinoma Trial (QEQ278)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- +3 more
- QEQ278
- (no location specified)
Jul 14, 2022